| Type | Post | Author | Replies | Last updated |
|---|---|---|---|---|
| News Article | Determining genetic signature of lung tumors can help guide treatment | harminka | 1 | 3 years 48 weeks ago |
| News Article | Sorafenib with carboplatin adds no benefit in lung cancer | harminka | 1 | 4 years 4 weeks ago |
| News Article | Thalidomide shows promise for treatment of recurrent ovarian cancer | harminka | 1 | 4 years 12 weeks ago |
| News Article | Novel bifunctional targeting agent | harminka | 1 | 4 years 30 weeks ago |
| News Article | Patients perceived cancer care unaffected by lower Medicare reimbursements | harminka | 1 | 4 years 33 weeks ago |
| News Article | Test Identifies Patients Who Benefit From Targeted Drugs | gdpawel | 0 | 4 years 33 weeks ago |
| News Article | Genomic profiling of lung tumors helps doctors choose most effective treatment | harminka | 1 | 4 years 33 weeks ago |
| News Article | Brain tumors need treatment with multiple 'targeted' drugs | harminka | 1 | 4 years 33 weeks ago |
| News Article | Outcome of Progression-Free Survival May Result in Biased Trial Results | harminka | 1 | 5 years 6 weeks ago |
gdpawel
